Ratings Harte Hanks, Inc.

Equities

HHS

US4161962026

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
7.33 USD -0.81% Intraday chart for Harte Hanks, Inc. -0.81% +7.95%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.17 for the 2024 fiscal year.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past twelve months, EPS forecast has been revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Advertising & Marketing

1st Jan change Capi. Investor Rating ESG Refinitiv
+7.95% 53.08M -
-12.93% 1.91B
B-
-25.00% 510M - -
-31.74% 364M - -
+22.01% 174M
C
-47.69% 116M - -
+11.21% 113M - -
+59.79% 87.54M -
+3.37% 85.38M - -
-33.07% 74.45M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. HHS Stock
  4. Ratings Harte Hanks, Inc.